OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 51 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,000 | -78.6% | 15,319 | +47.7% | 0.00% | – |
| Q4 2017 | $14,000 | -77.4% | 10,375 | -64.5% | 0.00% | – |
| Q3 2017 | $62,000 | -13.9% | 29,234 | +16.4% | 0.00% | – |
| Q2 2017 | $72,000 | -72.5% | 25,113 | -67.3% | 0.00% | – |
| Q1 2017 | $262,000 | +107.9% | 76,910 | +5.6% | 0.00% | – |
| Q4 2016 | $126,000 | -90.3% | 72,816 | -81.3% | 0.00% | – |
| Q3 2016 | $1,293,000 | – | 389,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 542,755 | $944,000 | 0.47% |
| BVF INC/IL | 734,976 | $1,279,000 | 0.26% |
| Old West Investment Management, LLC | 206,018 | $358,000 | 0.22% |
| Foresite Capital Management III, LLC | 254,257 | $442,000 | 0.19% |
| Baupost Group | 2,226,839 | $3,875,000 | 0.05% |
| Rhenman & Partners Asset Management AB | 120,000 | $209,000 | 0.04% |
| NEA Management Company, LLC | 370,900 | $645,000 | 0.03% |
| Rock Springs Capital Management LP | 165,300 | $288,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 22,934 | $40,000 | 0.01% |
| Telemetry Investments, L.L.C. | 10,250 | $18,000 | 0.01% |